AN
CelLBxHealth plc
ANPCY · OTC
$0.07 +0.00% (+$0.00)
Market Cap £1.63M
P/E Ratio -
Div. Yield -
ROE 104.73%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.62x
P/B 0.14x
P/E N/A
Growth
61 /100
Stable Rev. growth 6.10%
Book val. growth 14.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 62.27%
Net margin 601.37%
Op. margin 627.67%
Quality
2 /100
Poor ROIC 105.60%
ROE 104.73%
ROA 87.26%
Debt
80 /100
Low Debt/Equity 0.31x
Current ratio 3.13x
Int. coverage -38.21x
Stability
42 /100
Moderate Beta 0.14x
Rev. volatility 23.15%
EPS volatility 19.40%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ANPCY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Peter Collins
Employees
119
Headquarters
Guildford